New COVID-19 Findings from University of the Witwatersrand Described [Durability of Chadox1 Ncov-19 (Azd1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron Ba.1 and Ba.4 6 Months After Vaccination (Cov005): a Post-hoc ...]

MLA

“New COVID-19 Findings from University of the Witwatersrand Described [Durability of Chadox1 Ncov-19 (Azd1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron Ba.1 and Ba.4 6 Months After Vaccination (Cov005): A Post-Hoc ...].” AIDS Vaccine Week, 17 Apr. 2023, p. 362. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.745813497&authtype=sso&custid=ns315887.

APA

New COVID-19 Findings from University of the Witwatersrand Described [Durability of Chadox1 Ncov-19 (Azd1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron Ba.1 and Ba.4 6 Months After Vaccination (Cov005): a Post-hoc ...]. (2023, April 17). AIDS Vaccine Week, 362.

Chicago

AIDS Vaccine Week. 2023. “New COVID-19 Findings from University of the Witwatersrand Described [Durability of Chadox1 Ncov-19 (Azd1222) Vaccine and Hybrid Humoral Immunity Against Variants Including Omicron Ba.1 and Ba.4 6 Months After Vaccination (Cov005): A Post-Hoc ...],” April 17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.745813497&authtype=sso&custid=ns315887.